Maya Health is a technology company.
Maya Health has raised $100K across 1 funding round.
Maya Health has raised $100K in total across 1 funding round.
Maya Health has raised $100K in total across 1 funding round.
Maya Health's investors include Mystic Ventures, PsyMed Ventures.
Maya Health is a technology company that builds a software platform focused on tracking, measuring, and illustrating health outcomes, specifically in the emerging field of psychedelic medicine. It serves practitioners, participants, and researchers involved in psychedelic healthcare by providing real-world data to support safe and effective practices. The platform addresses the problem of fragmented data and lack of standardized outcome measurement in psychedelic therapy, enabling better clinical decision-making and research collaboration. Since its founding in 2019, Maya Health has shown growth momentum by establishing itself as a key player in this niche healthcare technology space, with a small but specialized team and funding under $5 million[1][3][6].
Maya Health was founded in 2019 and is headquartered in Denver, Colorado. The company was co-founded by David Champion, who serves as CEO. The idea emerged from the need to better understand and optimize the therapeutic journey in psychedelic medicine, a field that is rapidly evolving but lacks comprehensive data infrastructure. Early traction came from building a platform that connects psychedelic providers, participants, and researchers to collectively chart safe and effective practices, which has helped Maya carve out a unique position in this specialized healthcare segment[1][3][4][6].
Maya Health rides the wave of increasing acceptance and legalization of psychedelic therapies for mental health conditions, a trend driven by growing scientific evidence and regulatory shifts. The timing is critical as the psychedelic medicine field transitions from experimental to more mainstream clinical practice, creating demand for robust data platforms to ensure safety, efficacy, and regulatory compliance. Market forces such as rising mental health awareness, digital health adoption, and AI-driven analytics favor Maya Health’s growth. By providing infrastructure for outcome tracking and data sharing, Maya Health influences the broader ecosystem by enabling safer, more effective psychedelic treatments and accelerating research in this novel therapeutic area[1][3][4][6].
Looking ahead, Maya Health is poised to expand its platform capabilities, potentially integrating advanced AI analytics and broader clinical data to deepen insights into psychedelic therapy outcomes. Trends such as increased regulatory approvals, insurance coverage, and mainstream adoption of psychedelic treatments will shape its journey. As the psychedelic healthcare ecosystem matures, Maya Health’s influence may grow from a niche data provider to a foundational technology partner for providers, researchers, and regulators, helping to standardize and scale safe psychedelic medicine practices globally. This evolution ties back to its core mission of empowering the psychedelic medicine community through data-driven insights and collaboration[1][3][4][6].
Maya Health has raised $100K across 1 funding round. Most recently, it raised $100K Seed in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2020 | $100K Seed | Mystic Ventures, PsyMed Ventures |